Unique Risks, Benefits, and Challenges of Developing Drug-Drug Combination Products in a Pharmaceutical Industrial Setting

Overview of attention for article published in Combination Products in Therapy, March 2012

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)

Mentioned by

twitter: 1 X user

patent: 5 patents

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 90 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 5 patents that reference this research output.

FIXED DOSE COMBINATIONS OF CHS-131 AND A PPAR AGONIST

Application WO-2022051323-A1

World Intellectual Property Organisation (WIPO)

FIXED DOSE COMBINATIONS OF CHS-131 AND A DPP-4 INHIBITOR

Application WO-2022051319-A1

World Intellectual Property Organisation (WIPO)

FIXED DOSE COMBINATIONS OF CHS-131 AND A SGLT-2 INHIBITOR

Application WO-2022051316-A1

World Intellectual Property Organisation (WIPO)

FIXED DOSE COMBINATIONS OF CHS-131 AND A THYROID RECEPTOR BETA AGONIST

Application WO-2022051318-A1

World Intellectual Property Organisation (WIPO)

FIXED DOSE COMBINATIONS OF CHS-131 AND A FXR AGONIST

Application WO-2022051321-A1

World Intellectual Property Organisation (WIPO)